Companies: 10,795·Total market cap: $144.5T
Surmodics, Inc.

Surmodics, Inc.

SRDXNASDAQHealthcare
$42.98
+$0.15(+0.35%)
Market Cap$614511837
P/E Ratio
52W High$43.0048
52W Low$25.87

Surmodics, Inc. (SRDX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

srdx · stock forecast · 7 analysts (3M) · FMP · updated Nov 26, 2025

Analyst Rating & Consensus

Based on 7 Wall Street analysts in the past 3 months

SellBuy

Buy

7 analysts

consensus

Rating Breakdown

Strong Buy
1
Buy
3
Hold
2
Sell
1
Strong Sell
0
Total: 7 · Buy rate: 57.1%

12-Month Price Target

High

$43.00

Consensus

$39.50

-8.1% upside

Low

$36.00

Median: $39.5 · Last Close: $42.98

The Surmodics, Inc. (SRDX) analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month SRDX price target is $39.50, representing -8.1% upside from the current price of $42.98.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $40 (-8.1%)

Consensus Target

$39.50

-8.1% upside

High Target

$43

0.0%

Low Target

$36

-16.2%

Current Price

$42.98

as of today

Based on analyst price targets, the SRDX stock price prediction for the next 12 months ranges from $36 to $43. The consensus SRDX price forecast of $39.50 implies -8.1% upside from the current price of $42.98.

Short-Term Price Prediction

Ranging

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$42.980.00%

1-day model range: $42.92–$43.04. Peak: $43.04 (+0.00%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

21%79%0%
3Buy
11Neutral
0Sell
RSI (14)50.0Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · SRDX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$42.98NEUTRAL
MA 10$42.83BUY
MA 20$0.00NEUTRAL
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $SRDX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$42.93BUY
EMA 10$42.61BUY
EMA 20$0.00NEUTRAL
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $SRDX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Barrington Research2025-11-14
Downgrade ↓
Market PerformUnderperform
Barrington Research2025-08-11
Maintains
Market PerformMarket Perform
Needham2025-04-30
Maintains
HoldHold
Lake Street2025-03-07
Upgrade ↑
HoldBuy
Needham2025-01-30
Maintains
HoldHold
Barrington Research2024-05-30
Downgrade ↓
OutperformMarket Perform
Needham2024-05-29
Downgrade ↓
BuyHold
Sidoti & Co.2024-05-29
Downgrade ↓
BuyNeutral
Lake Street2024-05-29
Downgrade ↓
BuyHold
Barrington Research2024-05-02
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Surmodics, Inc. (SRDX) stock. Of the recent 43 rating actions, 7 were upgrades and 10 were downgrades. 7 analysts currently cover SRDX.

Analyst Recommendation Trends

Buy ratings202
Hold ratings404
Sell ratings01↑ +1

SRDX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$138M

↑ 17.3% YoY

Revenue Next Year

$123M

↓ 10.8% YoY

EPS This Year

$0.39

EPS Next Year

$-0.56

↓ 241.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SRDX EPS of $0.39 for the current fiscal year, based on estimates from 1 analysts. The SRDX revenue forecast is $138M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The SRDX stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SRDX price target is $39.50 (-8.1% upside), with an analyst consensus of Buy.

The SRDX short-term stock prediction for tomorrow is $42.98 (+0.00%).

Surmodics, Inc. trades on NASDAQ under the ticker SRDX. The SRDX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 57% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

SRDX forecast · 8 questions

According to 7 Wall Street analysts, the average 12-month SRDX price target is $39.50, with a high forecast of $43.00 and a low of $36.00. The median price target is shown in the chart above when available. This implies -8.1% potential upside from the current price of $42.98.

SRDX price targetWhat is SRDX price targetSRDX analyst price targetSRDX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.